Profile
Donald C.
Fresne served as the Chairman, President, and Chief Executive Officer of Epigen, Inc. from 1991 to 2010.
He also served as the President and Chief Executive Officer of Egenix, Inc. from 2012 to 2014.
Former positions of Donald C. Fresne
Companies | Position | End |
---|---|---|
Egenix, Inc.
Egenix, Inc. BiotechnologyHealth Technology Part of Denan, Inc., Egenix, Inc. engages in cancer therapeutics research and development. The company is based in Millbrook, NY. Egenix was acquired by Denan, Inc. on June 10, 2015 for $0.82 million. | Chief Executive Officer | 18/12/2014 |
Epigen, Inc.
Epigen, Inc. Medical SpecialtiesHealth Technology Epigen, Inc. develops products to monitor, diagnose and treat cancer n a more effective, less expensive and less invasive manner than other products currently available. The company is in the process of completing the development of its in-vitro blood test, a confirmatory test for prostate cancer. This employs the use of the HC Antigen. It was founded on April 24, 1991. | Chairman | 22/09/2010 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Epigen, Inc.
Epigen, Inc. Medical SpecialtiesHealth Technology Epigen, Inc. develops products to monitor, diagnose and treat cancer n a more effective, less expensive and less invasive manner than other products currently available. The company is in the process of completing the development of its in-vitro blood test, a confirmatory test for prostate cancer. This employs the use of the HC Antigen. It was founded on April 24, 1991. | Health Technology |
Egenix, Inc.
Egenix, Inc. BiotechnologyHealth Technology Part of Denan, Inc., Egenix, Inc. engages in cancer therapeutics research and development. The company is based in Millbrook, NY. Egenix was acquired by Denan, Inc. on June 10, 2015 for $0.82 million. | Health Technology |
- Stock Market
- Insiders
- Donald C. Fresne